APGZX
Price
$123.13
Change
-$2.07 (-1.65%)
Updated
Nov 13 closing price
Net Assets
27.19B
GFACX
Price
$74.18
Change
-$1.66 (-2.19%)
Updated
Nov 13 closing price
Net Assets
340.4B
Interact to see
Advertisement

APGZX vs GFACX

Header iconAPGZX vs GFACX Comparison
Open Charts APGZX vs GFACXBanner chart's image
AB Large Cap Growth Z
Price$123.13
Change-$2.07 (-1.65%)
VolumeN/A
Net Assets27.19B
American Funds Growth Fund of Amer C
Price$74.18
Change-$1.66 (-2.19%)
VolumeN/A
Net Assets340.4B
APGZX vs GFACX Comparison Chart in %
View a ticker or compare two or three
VS
APGZX vs. GFACX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGZX is a Buy and GFACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 340B vs. APGZX (27.2B). APGZX pays higher dividends than GFACX: APGZX (0.08) vs GFACX (0.00). APGZX was incepted earlier than GFACX: APGZX (10 years) vs GFACX (25 years). GFACX (1.36) is less costly to investors than APGZX (0.51). APGZX is a more actively managed with annual turnover of: 30.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than APGZX: GFACX (250) vs APGZX (2000000). GFACX annual gain was more profitable for investors over the last year : 4.61 vs. APGZX (4.31). APGZX return over 5 years is better than : 53.63 vs. GFACX (27.87).
APGZXGFACXAPGZX / GFACX
Total Expense Ratio0.511.3638%
Annual Report Gross Expense Ratio0.511.3638%
Fund Existence10 years25 years-
Gain YTD12.66416.34377%
Front LoadN/AN/A-
Min. Initial Investment2000000250800,000%
Min. Initial Investment IRAN/AN/A-
Net Assets27.2B340B8%
Annual Yield % from dividends0.080.00-
Returns for 1 year4.314.6193%
Returns for 3 years69.8156.17124%
Returns for 5 years53.6327.87192%
Returns for 10 years185.0175.78244%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAX18.70N/A
N/A
Baxter International
OFG40.72-0.03
-0.07%
OFG Bancorp
CVGW21.90-0.23
-1.04%
Calavo Growers
FBIOP6.53-0.27
-3.97%
Fortress Biotech
ACRV2.07-0.21
-9.21%
Acrivon Therapeutics